Article Versions Notes

Alipanah N, Shete PB, Nguyen H, Nguyen NV, Luu L, Pham T, Nguyen H, Nguyen P, Tran MC, Pham N, et al. Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening. Diagnostics. 2019; 9(2):56. https://doi.org/10.3390/diagnostics9020056

Alipanah, Narges, Priya B. Shete, Hanh Nguyen, Nhung Viet Nguyen, Lien Luu, Thuong Pham, Hung Nguyen, Phuong Nguyen, Minh Chi Tran, Nam Pham, and et al. 2019. "Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening" Diagnostics 9, no. 2: 56. https://doi.org/10.3390/diagnostics9020056

Alipanah, N., Shete, P. B., Nguyen, H., Nguyen, N. V., Luu, L., Pham, T., Nguyen, H., Nguyen, P., Tran, M. C., Pham, N., Phan, H., Phillips, P. P. J., Cattamanchi, A., & Nahid, P. (2019). Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening. Diagnostics, 9(2), 56. https://doi.org/10.3390/diagnostics9020056